Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs
- 1 March 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 29 (3) , 239-252
- https://doi.org/10.1016/0168-3659(94)90071-x
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Intranasal administration of human fibroblast interferon in mice, rats, rabbits and dogs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidasesLife Sciences, 1990
- Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.Journal of Pharmacobio-Dynamics, 1989
- Enzymic properties of intestinal aminopeptidase P: A new continuous assayFEBS Letters, 1988
- Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: Similarities in rates and involvement of aminopeptidasesLife Sciences, 1986
- Ciliary function in health and diseaseRespiratory Medicine, 1985
- Hydrolysis of leucine enkephalin in the nasal cavity of the rat — A possible factor in the low bioavailability of nasally administered peptidesBiochemical and Biophysical Research Communications, 1985
- Comparison of water influx and sieving coefficient in rat jejunal, rectal and nasal absorptions of antipyrine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- The basic trypsin inhibitor of bovine pancreas IV. The linear sequence of the 58 amino acidsBiochemical and Biophysical Research Communications, 1965
- Activity of insulin degraded by leucine aminopeptidaseBiochimica et Biophysica Acta, 1958